The peroxisome proliferator-activated receptor α activator, Wy14,643, is anti-inflammatory in vivo

Author： Colville-Nash Paul   Willis Dean   Papworth Jonathan   Freemantle Claire   Lam Connie   Andrews Gemma   Willoughby Derek  

Publisher： VSP

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.12, Iss.5-6, 2004-12, pp. : 493-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome Proliferator-Activated Receptor (PPAR)-α: A Pharmacological Target with a Promising Future

By van Raalte Daniel H.   Li Min   Pritchard P. Haydn   Wasan Kishor M.  

Pharmaceutical Research, Vol. 21, Iss. 9, 2004-09 ,pp. : 1531-1538

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor ligands in atherosclerosis

By Viles-Gonzalez Juan F   Choi Brian G   Fuster Valentin   Badimon Juan J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Peroxisome Proliferator-Activated Receptor Science

By  

Current Medicinal Chemistry, Vol. 10, Iss. 4, 2003-01 ,pp. : 267-280

Bentham Science Publishers

Access to resources Recommend Favorite

Cortical Expression of Peroxisome Proliferator-activated Receptor-α After Human Brain Contusion

By Feng D   Zhang Y   Chen G  

The Journal of International Medical Research, Vol. 36, Iss. 4, 2008-07 ,pp. : 783-791

Field House Publishing

Access to resources Recommend Favorite

Synthetic ligands for peroxisome proliferator-activated receptor-α, review of the patent literature 2000 – 2003

By Miyachi Hiroyuki  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 607-618

Informa Healthcare

Access to resources Recommend Favorite